Annual CFO
$6.82 M
+$1.99 M+41.36%
December 31, 2023
Summary
- As of February 7, 2025, ETON annual cash flow from operations is $6.82 million, with the most recent change of +$1.99 million (+41.36%) on December 31, 2023.
- During the last 3 years, ETON annual CFO has risen by +$29.16 million (+130.50%).
- ETON annual CFO is now at all-time high.
Performance
ETON Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$2.95 M
+$1.70 M+135.22%
September 30, 2024
Summary
- As of February 7, 2025, ETON quarterly cash flow from operations is $2.95 million, with the most recent change of +$1.70 million (+135.22%) on September 30, 2024.
- Over the past year, ETON quarterly CFO has increased by +$2.56 million (+662.79%).
- ETON quarterly CFO is now -58.44% below its all-time high of $7.10 million, reached on June 30, 2023.
Performance
ETON Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$2.12 M
+$2.08 M+4950.00%
September 30, 2024
Summary
- As of February 7, 2025, ETON TTM cash flow from operations is $2.12 million, with the most recent change of +$2.08 million (+4950.00%) on September 30, 2024.
- Over the past year, ETON TTM CFO has dropped by -$4.69 million (-68.88%).
- ETON TTM CFO is now -77.11% below its all-time high of $9.27 million, reached on September 30, 2023.
Performance
ETON TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ETON Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.4% | +662.8% | -68.9% |
| 3 y3 years | +130.5% | -58.4% | -68.3% |
| 5 y5 years | +183.7% | -58.4% | -68.3% |
ETON Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +244.4% | -58.4% | +157.7% | -77.1% | +129.4% |
| 5 y | 5-year | at high | +130.5% | -58.4% | +140.9% | -77.1% | +109.5% |
| alltime | all time | at high | +130.5% | -58.4% | +140.9% | -77.1% | +109.5% |
Eton Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.95 M(+135.2%) | $2.12 M(+4950.0%) |
| Jun 2024 | - | $1.25 M(-150.7%) | $42.00 K(-99.3%) |
| Mar 2024 | - | -$2.47 M(-739.0%) | $5.89 M(-13.6%) |
| Dec 2023 | $6.82 M(+41.4%) | $387.00 K(-55.7%) | $6.82 M(-26.5%) |
| Sep 2023 | - | $873.00 K(-87.7%) | $9.27 M(+38.5%) |
| Jun 2023 | - | $7.10 M(-558.9%) | $6.69 M(+226.4%) |
| Mar 2023 | - | -$1.55 M(-154.5%) | $2.05 M(-57.5%) |
| Dec 2022 | $4.82 M(-202.1%) | $2.84 M(-266.8%) | $4.82 M(-253.7%) |
| Sep 2022 | - | -$1.70 M(-169.2%) | -$3.14 M(-28.5%) |
| Jun 2022 | - | $2.46 M(+101.2%) | -$4.38 M(-39.2%) |
| Mar 2022 | - | $1.22 M(-123.9%) | -$7.21 M(+52.8%) |
| Dec 2021 | -$4.72 M | -$5.12 M(+73.5%) | -$4.72 M(-30.4%) |
| Sep 2021 | - | -$2.95 M(+699.5%) | -$6.79 M(-24.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$369.00 K(-109.9%) | -$8.93 M(-21.8%) |
| Mar 2021 | - | $3.71 M(-151.7%) | -$11.41 M(-48.9%) |
| Dec 2020 | -$22.35 M(+24.0%) | -$7.18 M(+41.0%) | -$22.35 M(+17.5%) |
| Sep 2020 | - | -$5.09 M(+78.5%) | -$19.01 M(+11.0%) |
| Jun 2020 | - | -$2.85 M(-60.5%) | -$17.13 M(-7.3%) |
| Mar 2020 | - | -$7.22 M(+87.6%) | -$18.48 M(+2.5%) |
| Dec 2019 | -$18.03 M(+121.3%) | -$3.85 M(+19.7%) | -$18.03 M(+13.0%) |
| Sep 2019 | - | -$3.21 M(-23.4%) | -$15.95 M(+6.1%) |
| Jun 2019 | - | -$4.20 M(-38.0%) | -$15.03 M(+15.1%) |
| Mar 2019 | - | -$6.77 M(+281.5%) | -$13.06 M(+60.4%) |
| Dec 2018 | -$8.14 M | -$1.77 M(-22.6%) | -$8.14 M(+27.8%) |
| Sep 2018 | - | -$2.29 M(+2.9%) | -$6.37 M(+56.2%) |
| Jun 2018 | - | -$2.23 M(+20.4%) | -$4.08 M(+120.4%) |
| Mar 2018 | - | -$1.85 M | -$1.85 M |
FAQ
- What is Eton Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Eton Pharmaceuticals?
- What is Eton Pharmaceuticals annual CFO year-on-year change?
- What is Eton Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Eton Pharmaceuticals?
- What is Eton Pharmaceuticals quarterly CFO year-on-year change?
- What is Eton Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Eton Pharmaceuticals?
- What is Eton Pharmaceuticals TTM CFO year-on-year change?
What is Eton Pharmaceuticals annual cash flow from operations?
The current annual CFO of ETON is $6.82 M
What is the all time high annual CFO for Eton Pharmaceuticals?
Eton Pharmaceuticals all-time high annual cash flow from operations is $6.82 M
What is Eton Pharmaceuticals annual CFO year-on-year change?
Over the past year, ETON annual cash flow from operations has changed by +$1.99 M (+41.36%)
What is Eton Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ETON is $2.95 M
What is the all time high quarterly CFO for Eton Pharmaceuticals?
Eton Pharmaceuticals all-time high quarterly cash flow from operations is $7.10 M
What is Eton Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ETON quarterly cash flow from operations has changed by +$2.56 M (+662.79%)
What is Eton Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ETON is $2.12 M
What is the all time high TTM CFO for Eton Pharmaceuticals?
Eton Pharmaceuticals all-time high TTM cash flow from operations is $9.27 M
What is Eton Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ETON TTM cash flow from operations has changed by -$4.69 M (-68.88%)